blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP Citations: EP4006053

Cited inSearch
Type:Patent literature
Publication No.:EP3072905  [IY]
 (SHANGHAI HENGRUI PHARM CO LTD et al.) [I] 1-15 * example 6; claims 1-32 *[Y] 4-6,8
Type:Non-patent literature
Publication information:[XY]   GLATT SOPHIE: "Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation", 23 December 2017 (2017-12-23), pages 523 - 532, XP055960145, Retrieved from the Internet [retrieved on 20220912] [X] 1-3,7,9-11,13-15 * abstract * [Y] 4-6,8
Type:Non-patent literature
Publication information:[XY]   SILFVAST-KAISER ANNIKA ET AL: "Anti-IL17 therapies for psoriasis", vol. 19, no. 1, 31 December 2018 (2018-12-31), pages 45 - 54, XP009539080, ISSN: 1744-7682, Retrieved from the Internet [retrieved on 20181208], DOI: 10.1080/14712598.2019.1555235 [X] 1-3,9,11-15 * abstract; figure 1 * * page 47, column r, paragraph 2 * * page 48, column l, paragraph last - page 49, column r, paragraph 1 *[Y] 4-6,8
DOI: http://dx.doi.org/10.1080/14712598.2019.1555235